Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000197

CHIEF OPERATING OFFICER gave up 2,590 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Williams Gregory C. CHIEF OPERATING OFFICER 2020-01-30 Option exercise +7,500 7,500 D
Williams Gregory C. CHIEF OPERATING OFFICER 2020-01-30 Shares withheld for taxes −2,590 $3.91 $10,127 4,910 D
Derivatives
Williams Gregory C. CHIEF OPERATING OFFICER 2020-01-30 Option exercise · Restricted Stock Units +7,500 22,500 D
Loading xslF345X03/form4-01312020_050112.xml…